Literature DB >> 20094655

A miniaturized screen for inhibitors of Jumonji histone demethylases.

Masaaki Sakurai1, Nathan R Rose, Lena Schultz, Amy M Quinn, Ajit Jadhav, Stanley S Ng, Udo Oppermann, Christopher J Schofield, Anton Simeonov.   

Abstract

2-Oxoglutarate- and Fe(ii)-dependent oxygenases are a major class of N(epsilon)-methyl lysine demethylases that are involved in epigenetic regulation. Assays suitable for implementation in a high-throughput manner have been lacking for these enzymes. Here, we describe the design and implementation of a robust and miniaturized high-throughput kinetic assay for inhibitors of JMJD2E using a formaldehyde dehydrogenase-coupled reaction with real-time fluorescence detection. Reactant compatibility studies resulted in simplification of the assay scheme to the mixing of two reagent solutions, both of which were stable overnight. The assay was miniaturized to a 4 microL volume in 1536-well format and was used to screen the library of pharmacologically active compounds (LOPAC(1280)). Inhibitors identified by the screen were further characterized in secondary assays including FDH counterscreen and demethylation assays that monitored demethylation by MALDI-TOF MS. The assay developed here will enable the screening of large compound libraries against the Jumonji demethylases in a robust and automated fashion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20094655      PMCID: PMC3401096          DOI: 10.1039/b912993f

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  39 in total

1.  A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.

Authors:  Susan L McGovern; Emilia Caselli; Nikolaus Grigorieff; Brian K Shoichet
Journal:  J Med Chem       Date:  2002-04-11       Impact factor: 7.446

2.  Compound Management for Quantitative High-Throughput Screening.

Authors:  Adam Yasgar; Paul Shinn; Ajit Jadhav; Douglas Auld; Sam Michael; Wei Zheng; Christopher P Austin; James Inglese; Anton Simeonov
Journal:  JALA Charlottesv Va       Date:  2008-04

3.  Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity.

Authors:  Lurdes Mira; M Tereza Fernandez; Marta Santos; Rui Rocha; M Helena Florêncio; Keith R Jennings
Journal:  Free Radic Res       Date:  2002-11

4.  Synthesis and activity of N-oxalylglycine and its derivatives as Jumonji C-domain-containing histone lysine demethylase inhibitors.

Authors:  Shohei Hamada; Tae-Dong Kim; Takayoshi Suzuki; Yukihiro Itoh; Hiroki Tsumoto; Hidehiko Nakagawa; Ralf Janknecht; Naoki Miyata
Journal:  Bioorg Med Chem Lett       Date:  2009-03-26       Impact factor: 2.823

5.  Flavonoids induce HIF-1alpha but impair its nuclear accumulation and activity.

Authors:  Anastasia Triantafyllou; Ilias Mylonis; George Simos; Sophia Bonanou; Andreas Tsakalof
Journal:  Free Radic Biol Med       Date:  2007-11-07       Impact factor: 7.376

Review 6.  Novel drugs and the response to hypoxia: HIF stabilizers and prolyl hydroxylase.

Authors:  Masaomi Nangaku; Ichiro Kojima; Tetsuhiro Tanaka; Takamoto Ohse; Hideki Kato; Toshiro Fujita
Journal:  Recent Pat Cardiovasc Drug Discov       Date:  2006-06

7.  Aminosuberoyl hydroxamic acids (ASHAs): a potent new class of HDAC inhibitors.

Authors:  Sandro Belvedere; David J Witter; Jiaming Yan; J Paul Secrist; Victoria Richon; Thomas A Miller
Journal:  Bioorg Med Chem Lett       Date:  2007-04-29       Impact factor: 2.823

8.  Selective inhibition of factor inhibiting hypoxia-inducible factor.

Authors:  Michael A McDonough; Luke A McNeill; Melanie Tilliet; Cyril A Papamicaël; Qiu-Yun Chen; Biswadip Banerji; Kirsty S Hewitson; Christopher J Schofield
Journal:  J Am Chem Soc       Date:  2005-06-01       Impact factor: 15.419

Review 9.  Structural studies on 2-oxoglutarate oxygenases and related double-stranded beta-helix fold proteins.

Authors:  Ian J Clifton; Michael A McDonough; Dominic Ehrismann; Nadia J Kershaw; Nicolas Granatino; Christopher J Schofield
Journal:  J Inorg Biochem       Date:  2006-03-02       Impact factor: 4.155

10.  Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294.

Authors:  Yanqi Chang; Xing Zhang; John R Horton; Anup K Upadhyay; Astrid Spannhoff; Jin Liu; James P Snyder; Mark T Bedford; Xiaodong Cheng
Journal:  Nat Struct Mol Biol       Date:  2009-02-15       Impact factor: 15.369

View more
  35 in total

Review 1.  Chemical and biochemical approaches in the study of histone methylation and demethylation.

Authors:  Keqin Kathy Li; Cheng Luo; Dongxia Wang; Hualiang Jiang; Y George Zheng
Journal:  Med Res Rev       Date:  2012-07       Impact factor: 12.944

Review 2.  Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases.

Authors:  Zhanxin Wang; Dinshaw J Patel
Journal:  Q Rev Biophys       Date:  2013-09-02       Impact factor: 5.318

3.  Inhibition of histone demethylases by 4-carboxy-2,2'-bipyridyl compounds.

Authors:  Kai-Hsuan Chang; Oliver N F King; Anthony Tumber; Esther C Y Woon; Tom D Heightman; Michael A McDonough; Christopher J Schofield; Nathan R Rose
Journal:  ChemMedChem       Date:  2011-03-15       Impact factor: 3.466

Review 4.  The role of histone demethylases in cancer therapy.

Authors:  Inga Hoffmann; Martin Roatsch; Martin L Schmitt; Luca Carlino; Martin Pippel; Wolfgang Sippl; Manfred Jung
Journal:  Mol Oncol       Date:  2012-08-07       Impact factor: 6.603

5.  Targeting Histone Demethylases: A New Avenue for the Fight against Cancer.

Authors:  Dante Rotili; Antonello Mai
Journal:  Genes Cancer       Date:  2011-06

6.  Development of homogeneous luminescence assays for histone demethylase catalysis and binding.

Authors:  Akane Kawamura; Anthony Tumber; Nathan R Rose; Oliver N F King; Michelle Daniel; Udo Oppermann; Tom D Heightman; Christopher Schofield
Journal:  Anal Biochem       Date:  2010-05-21       Impact factor: 3.365

Review 7.  High-throughput screening to identify inhibitors of lysine demethylases.

Authors:  Molly Gale; Qin Yan
Journal:  Epigenomics       Date:  2015       Impact factor: 4.778

8.  Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2,4-diamino-7-aminoalkoxy-quinazolines.

Authors:  Feng Liu; Xin Chen; Abdellah Allali-Hassani; Amy M Quinn; Tim J Wigle; Gregory A Wasney; Aiping Dong; Guillermo Senisterra; Irene Chau; Alena Siarheyeva; Jacqueline L Norris; Dmitri B Kireev; Ajit Jadhav; J Martin Herold; William P Janzen; Cheryl H Arrowsmith; Stephen V Frye; Peter J Brown; Anton Simeonov; Masoud Vedadi; Jian Jin
Journal:  J Med Chem       Date:  2010-08-12       Impact factor: 7.446

Review 9.  Targeting protein lysine methylation and demethylation in cancers.

Authors:  Yunlong He; Ilia Korboukh; Jian Jin; Jing Huang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2012-01       Impact factor: 3.848

10.  Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen.

Authors:  Joyce Sayegh; Jian Cao; Mike Ran Zou; Alfonso Morales; Lauren P Blair; Michael Norcia; Denton Hoyer; Alan J Tackett; Jane S Merkel; Qin Yan
Journal:  J Biol Chem       Date:  2013-02-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.